Prosthesis UserNCT04787627
Clinical Investigation (Beta) of Power Knee Mainstream - Dynamic
A study testing Power Knee in people with Prosthesis User and Amputation, run by Össur Iceland ehf at 2 sites in United States.
Trial summary
Prospective two group cross over investigation, comparing the investigational device (Power Knee, a powered microprocessor controlled prosthetic knee) and subjects prescribed microprocessor prosthetic knee (MPK). Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Prosthesis User, Amputation
- What is being tested?
- Power Knee
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 17 participants
- Where
- 2 sitesUnited States
- Study dates
- 18 Nov 2019to 6 Jul 2020
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- 50Kg< body weight < 116Kg
- K3-K4 amputees with unilateral transfemoral amputation or Knee disarticulation
- Allows for 37mm knee center height to dome of pyramid alignment
- Currently using a MPK or Power Knee
- Older than 18 years old
- No socket issues/changes in the last 6 weeks and no socket changes expected during the duration of the study period.
- Comfortable and stable socket fit
- Willing and able to participate in the study and follow the protocol
Who cannot join
- 50Kg> body weight > 116Kg
- Bilateral amputees
- Users with socket problems
- Users with co-morbidities in the contra-lateral limb, which affect their functional mobility
- Younger than 18 years old
- Users with stump pain
- Users with cognitive impairment
- Users not involved in other clinical tests and/or receiving treatment that the testing might affect.
Trial locations and contacts
2 sites in 1 country.
United States2 sites
Medical Center Orthotics and Prosthetics
Boston, Massachusetts, 02134
Medical Center Orthotics and Prosthetics
Silver Spring, Maryland, 20910
About this study
Official title: Clinical Investigation (Beta) of Power Knee
Prospective two group cross over investigation, comparing the investigational device (Power Knee, a powered microprocessor controlled prosthetic knee) and subjects prescribed microprocessor prosthetic knee (MPK).
The primary objective was to evaluate the efficacy of the investigational device in reducing exertion during walking compared to passive MPKs. Additionally to evaluate the efficacy of the investigational device in the short and long term compared to passive MPKs and previous versions of the Power Knee, during daily living activities i.e. walking on level ground, in stairs and inclines, rising from and sitting down to a chair as well as performance of gait functions and ease of set up for average to highly active transfemoral/knee disarticulation amputees and Certified Prosthetists/Orthotists (CPOs).
Read the detailed description
This is a prospective two group cross-over study, within subject comparison. 3 study visits are planned for amputee subjects, with approximately 2-3 weeks between visits, and an optional fourth visit 8-12 weeks after the third visit. During the first visit subjects will be check for inclusion/exclusion, consented and randomly assigned into two groups and Group 1 (transitioning to the investigational device) will perform functional tests and answer questionnaires on the performance of their current prosthesis to provide baseline information. The Group 1 subjects will be fitted and trained on the investigational device and a recommended prosthetic foot which they will use as their prescribed prosthesis for 2-3 weeks until the second visit, the other half will stay on their prescribed prosthesis until the second visit.
During the second visit the subjects of Group 1 will perform the same functional tests as in the first visit on the investigational device and answer questionnaires on the performance of the investigational device, and then return to their prescribed prosthesis. The Group 2 will perform the same tests/questionnaires on their prescribed prosthesis and then be fitted and trained on the investigational device and use it as their usual prosthesis for 2-3 weeks.
During the third visit all subject will repeat the tests and questionnaires on the prosthesis they are fitted with (Group1 on the prescribed and Group 2 on the investigational device). Subjects will have the option to use the investigational device for an additional 8-12 weeks, those who choose that will be fitted with the investigational device or will stay on it, depending in which they are in at this point. They will be booked for the fourth visit; they will be contacted via telephone 4-5 weeks later and asked to provide feedback on their experience with the device so far. Those that choose not to keep using the investigational device will be returned to their prescribed prosthesis.
During the fourth visit subjects will answer the same questionnaires and perform the same functional tests as the other visits. Data will be collected from the knee on activity. They will then be fitted back to their prescribed prosthesis.
End of study. CPO (Certified Prosthetist Orthotist) subjects will answer a questionnaire on the ease of setup of the investigational device and provide feedback on the ease of setup of gait functions.
Statistical considerations:
Outcomes at each timepoint were visually inspected for normality using histograms and qq-plots, as well as a Shapiro-Wilk Normality Test. If the data were deemed to be normal the hypotheses were tested using a two-tailed, paired, student's t-test. Non-normal data was tested using the Wilcoxon signed-rank test.
- Conditions
- Prosthesis User, Amputation
- Being tested
- Power Knee
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Power KneeDevice
Powered microprocessor controlled prosthetic knee
| Study group | Role | What they receive |
|---|---|---|
| Power Knee before prescribed prosthesis | Experimental | Power Knee, the investigational device is fitted on subjects and they use it as their primary prosthesis for 2 weeks before coming in for data collection on the device. After being on the investigational device for 2 weeks subjects go back on their prescribed prosthesis for 2 weeks and comparator data is collected. Receives: Device: Power Knee |
| Power Knee after Prescribed prosthesis | Experimental | Subjects start the study by using their prescribed prosthesis for 2 weeks, then they come in for data collection of comparator data, in that same visit they are fitted with the investigational device and wear that for 2 weeks before coming in for data collection on that device. Receives: Device: Power Knee |
What is being measured
The primary outcome is the main question the study is designed to answer.
Mean Difference in Borg Category Rating Scale Before and After 6MWT at 2 Weeks
Mean difference in perceived exertion on the Borg rating scale of perceived exertion before and after 6 minute walk test (6MWT) (see outcome 2) with investigational device (Power Knee) compared to comparator (prescribed device). Subjects are asked how exerted they feel on a scale of 0-10 (0 indicating no exertion and 10 indicating the most exertion) at rest before they carry out the 6MWT, and after carrying out the 6MWT, the difference is recorded.
The Borg Category Rating 10 scale (CR10) is a validated measure of perceived exertion.
Measured: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
Average Distance Walked in 6 Minute Walk Test
Average distance walked in 6MWT with investigational device (Power Knee) compared to comparator (prescribed device) User walk for 6 minutes in their self selected walking speed on a 30 meter track.
Shorter time indicates better mobility performance.
Measured: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
Secondary outcomes (13)
Total Score of Prosthesis Mobility Questionnaire (PMQ) Questions 9 and 10
Support in sit to stand and stand to sit evaluation:
Total score (minimum score 0 - maximum score 8) of Prosthetic Mobility Questionnaire (PMQ) questions 9 and 10 with investigational device (Power Knee) compared to comparator (prescribed knee):
PMQ : Over the past 2 weeks, please rate your ability in the following activities when using your prosthesis (0=no ability, 4=fully able):
- Question 9. To sit down and get up from a chair with a high seat (e.g. a dining chair, an office chair)
- Question 10. To sit down and get up from a low, soft chair (e.g. a deep sofa) A higher total score on these PMQ items indicates a better outcome as it reflects greater functional ability, independence, and overall quality of life for individuals using a prosthesis.
The total score is obtained by summing the scores from questions 9 and 10.
Measured: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
Average Score of Modified Prosthesis Evaluation Questionnaire (PEQ) Question 14F
Average score with investigational device (Power Knee) compared to comparator (prescribed device) of modified PEQ Question 14F
Modified PEQ question 14F :
Over the past 2 weeks, please rate your ability in the following activities when using your prosthesis :
- Question 14F. Your safety when walking down a steep hill using the prosthesis The scale used is a Likert Scale 1-10 (1 indicating low rating of safety and 10 indicating a high rating of safety).
Measured: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
Average Score of Modified Prosthesis Evaluation Questionnaire (PEQ) Question 13D
Average score with investigational device (Power Knee) compared to comparator (prescribed device) of modified PEQ Question 13D
Over the past 2 weeks, please rate your ability in the following activities when using your prosthesis :
- Question 13D.Your safety when walking downstairs using the prosthesis The scale used is a Likert Scale 1-10 (1 indicating low rating of safety and 10 indicating a high rating of safety).
Measured: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
Satisfaction With Walking Speed
Proportion of subjects reporting satisfaction with walking speed on investigational device
Measured: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
Prosthetic Limb Users Survey of Mobility (PLUS-M) T-score
Ability to ambulate over typical environmental obstacles measured by the Prosthetic Limb Users Survey of Mobility (PLUS-M), T-score with Power Knee compared to comparator (prescribed device).
The Prosthetic Limb Users Survey of Mobility™ is a self-report instrument for measuring mobility of adults with lower limb amputation.
Scoring a PLUS-M short form produces a T-score. To find the T-score, the scores must be summed for all responses on the short form (creating a raw score). Then the raw score needs to be used to determine the T-score in the conversation table provided with the PLUS-M questionnaire.
The T-score is a standardized score with a mean of 50 and a standard deviation of 10. A higher T-score indicates a higher level of mobility. The highest possible T-score is 71.4 and the lowest one is 21.8.
Measured: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
Average Score of Modified Prosthesis Evaluation Questionnaire (PEQ) Question 13A
Average score with investigational device (Power Knee) compared to comparator (prescribed device) of modified PEQ Question 13A
Over the past 2 weeks, please rate your ability in the following activities when using your prosthesis :
- Question 13A. Your safety (during stance phase) when walking with your prosthesis (prescribed device) /test prosthesis (Power Knee)? The scale used is a Likert Scale 1-10 (1 indicating low rating of safety and 10 indicating a high rating of safety).
Measured: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
Average Score of Prosthesis Evaluation Questionnaire (PEQ) Question 1D
Average score with investigational device (Power Knee) compared to comparator (prescribed device) of modified PEQ Question 1D
Over the past 2 weeks, please rate your ability in the following activities when using your prosthesis :
- Question 1D. Your comfort while standing when using your prosthesis/test prosthesis? The scale used is a Likert Scale 1-10 (1 indicating low rating of safety and 10 indicating a high rating of safety).
Measured: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
Average Score Regarding the Ease of Setup
Self reported ease of setup of investigational device compared to state of the art microprocessor knees (SOTA MPKs) and previous version of the investigational device.
Average score with investigational device (Power Knee) compared to comparator (previous version of Power Knee) and compared to state of the art microprocessor knees (SOTA MPKs) The scale used is a Likert Scale 1-10 (1 indicating low rating and 10 indicating a high rating).
Measured: Immediately after the intervention (fitting of the investigational device)
Proportion of Participants With Average Score Over 5 on Questions 3K and 3L of the Prosthesis Evaluation Questionnaire (PEQ) With the Investigational Device
Proportion of participants with Average score with investigational device of PEQ questions 3K and 3L over 5
PEQ- Questions 3K, 3L:
- Question 3K: Over the past two weeks, rate how often the test prosthesis made squeaking, clicking, or belching sounds The scale used is a Likert Scale 1-10 (1 indicating low frequency of prosthesis making sounds and 10 indicating a high frequency of the prosthesis making sounds).
- Question 3L: 3L: If it made any sounds in the past four weeks, rate how bothersome these sounds were to you. - Or check It made no sounds The scale used is a Likert Scale 1-10 (1 indicating low frequency of prosthesis making sounds and 10 indicating a high frequency of the prosthesis making sounds).
Support question (yes/no) "Would the noise from the test device prevent you from preferring it as your usual prosthesis?"
Measured: After 2 weeks of either using the Power Knee or their own prescribed knee
Total Score of Prosthesis Mobility Questionnaire (PMQ) Questions 1 and 3-6:
Total score of PMQ questions 1,3-6 (minimum score 0 - maximum score 20):
PMQ (Questions 1 and 3-6):
Over the past 2 weeks, please rate your ability in the following activities when using your prosthesis:
- Question 1: To walk indoors
- Question 3: To walk upstairs
- Question 4: To walk downstairs
- Question 5: To walk up a steep hill
- Question 6: To walk down a steep hill The scale used is a Likert scale 0-4 (0= Unable or hardly able at all, 1= High difficulty, 2= Moderate Difficulty, 3= Little difficulty, 4= No problems or almost fully able).
Measured: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
Time Required to Complete the L-test
The L-Test of Functional Mobility consists of a series of movements designed to assess an individual's physical function and dynamic balance. The test involves the participant starting from a seated position, standing up, walking a short distance, turning, walking back, and returning to the seated position. The course typically forms an "L" shape, which includes two turns, and the total distance covered is longer than that of similar tests like the Timed Up and Go (TUG) test. The outcome measure is the time taken to complete these movements, providing an objective evaluation of the participant's functional mobility. There is no fixed minimum or maximum; lower times indicate better performance (i.e., faster completion reflects greater mobility).
Measured: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
Average Prosthetic Mobility Questionnaire (PMQ) Total Score
Average Prosthetic Mobility Questionnaire (PMQ) total score (minimum score 0 - maximum score 48) with investigational device (Power Knee) compared to comparator (prescribed device).
The Prosthetic Mobility Questionnaire is a tool for assessing mobility in people with lower-limb amputation, higher score indicates better mobility performance.
Measured: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
Occurrence of Side Effects That Could be Directly Related to Using the Power Knee
Evaluating the occurrence of side effects associated with the Power Knee entails systematically documenting and analyzing any adverse effects experienced by users throughout the 2 weeks of use.
Measured: After 2 weeks of using the Power Knee
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Mar 2021
- Study start18 Nov 2019
- Primary completion6 Jul 2020
- Study completion6 Jul 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for Prosthesis UserStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Model description
- This is a prospective randomized two group cross-over study, within subject comparison.
- Masking
- None (open label)
- Enrolment
- 17 participants (actual)
Sponsor and investigators
- Lead sponsor
- Össur Iceland ehf
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Medical Center Orthotics and Prosthetics
- Responsible party
- Sponsor
- Investigators
- Ian Fothergill, CPO, Principal investigator, Medical Center Orthotics and Prosthetics (MCOP) Silver SpringJohn Warren, CPO, Principal investigator, Medical Center Orthotics and Prosthetics (MCOP) Boston
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04787627
- Sponsor's protocol ID
- CIP2019050213
- Status last verified
- Sep 2025
- First submitted
- 29 Dec 2020
- Last updated
- 22 Sep 2025
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical Investigation (Beta) of Power Knee
- ClinicalTrials.gov ID
- NCT04787627
- Acronym / sponsor ID
- CIP2019050213
- Conditions
- Prosthesis User, Amputation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 17 participants (actual)
- Lead sponsor
- Össur Iceland ehfIndustry (pharma, biotech, devices)
- Collaborators
- Medical Center Orthotics and Prosthetics
- Study start
- 18 Nov 2019 (actual)
- Primary completion
- 6 Jul 2020 (actual)
- Study completion
- 6 Jul 2020 (actual)
- First posted
- 8 Mar 2021 (actual)
- Results
- Posted 22 Sep 2025
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Prospective two group cross over investigation, comparing the investigational device (Power Knee, a powered microprocessor controlled prosthetic knee) and subjects prescribed microprocessor prosthetic knee (MPK).
The primary objective was to evaluate the efficacy of the investigational device in reducing exertion during walking compared to passive MPKs. Additionally to evaluate the efficacy of the investigational device in the short and long term compared to passive MPKs and previous versions of the Power Knee, during daily living activities i.e. walking on level ground, in stairs and inclines, rising from and sitting down to a chair as well as performance of gait functions and ease of set up for average to highly active transfemoral/knee disarticulation amputees and Certified Prosthetists/Orthotists (CPOs).
Detailed description
This is a prospective two group cross-over study, within subject comparison. 3 study visits are planned for amputee subjects, with approximately 2-3 weeks between visits, and an optional fourth visit 8-12 weeks after the third visit. During the first visit subjects will be check for inclusion/exclusion, consented and randomly assigned into two groups and Group 1 (transitioning to the investigational device) will perform functional tests and answer questionnaires on the performance of their current prosthesis to provide baseline information. The Group 1 subjects will be fitted and trained on the investigational device and a recommended prosthetic foot which they will use as their prescribed prosthesis for 2-3 weeks until the second visit, the other half will stay on their prescribed prosthesis until the second visit.
During the second visit the subjects of Group 1 will perform the same functional tests as in the first visit on the investigational device and answer questionnaires on the performance of the investigational device, and then return to their prescribed prosthesis. The Group 2 will perform the same tests/questionnaires on their prescribed prosthesis and then be fitted and trained on the investigational device and use it as their usual prosthesis for 2-3 weeks.
During the third visit all subject will repeat the tests and questionnaires on the prosthesis they are fitted with (Group1 on the prescribed and Group 2 on the investigational device). Subjects will have the option to use the investigational device for an additional 8-12 weeks, those who choose that will be fitted with the investigational device or will stay on it, depending in which they are in at this point. They will be booked for the fourth visit; they will be contacted via telephone 4-5 weeks later and asked to provide feedback on their experience with the device so far. Those that choose not to keep using the investigational device will be returned to their prescribed prosthesis.
During the fourth visit subjects will answer the same questionnaires and perform the same functional tests as the other visits. Data will be collected from the knee on activity. They will then be fitted back to their prescribed prosthesis.
End of study. CPO (Certified Prosthetist Orthotist) subjects will answer a questionnaire on the ease of setup of the investigational device and provide feedback on the ease of setup of gait functions.
Statistical considerations:
Outcomes at each timepoint were visually inspected for normality using histograms and qq-plots, as well as a Shapiro-Wilk Normality Test. If the data were deemed to be normal the hypotheses were tested using a two-tailed, paired, student's t-test. Non-normal data was tested using the Wilcoxon signed-rank test.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- This is a prospective randomized two group cross-over study, within subject comparison.
| Arm | Type | Receives |
|---|---|---|
| Power Knee before prescribed prosthesis | Experimental | Device: Power KneePower Knee, the investigational device is fitted on subjects and they use it as their primary prosthesis for 2 weeks before coming in for data collection on the device. After being on the investigational device for 2 weeks subjects go back on their prescribed prosthesis for 2 weeks and comparator data is collected. |
| Power Knee after Prescribed prosthesis | Experimental | Device: Power KneeSubjects start the study by using their prescribed prosthesis for 2 weeks, then they come in for data collection of comparator data, in that same visit they are fitted with the investigational device and wear that for 2 weeks before coming in for data collection on that device. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (8 listed)
- 50Kg< body weight < 116Kg
- K3-K4 amputees with unilateral transfemoral amputation or Knee disarticulation
- Allows for 37mm knee center height to dome of pyramid alignment
- Currently using a MPK or Power Knee
- Older than 18 years old
Key exclusion criteria (8 listed)
- 50Kg> body weight > 116Kg
- Bilateral amputees
- Users with socket problems
- Users with co-morbidities in the contra-lateral limb, which affect their functional mobility
- Younger than 18 years old
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Power KneePowered microprocessor controlled prosthetic knee | Device | Power Knee after Prescribed prosthesis, Power Knee before prescribed prosthesis |
Primary outcome
Mean Difference in Borg Category Rating Scale Before and After 6MWT at 2 Weeks
Time frame: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
Mean difference in perceived exertion on the Borg rating scale of perceived exertion before and after 6 minute walk test (6MWT) (see outcome 2) with investigational device (Power Knee) compared to comparator (prescribed device). Subjects are asked how exerted they feel on a scale of 0-10 (0 indicating no exertion and 10 indicating the most exertion) at rest before they carry out the 6MWT, and after carrying out the 6MWT, the difference is recorded. The Borg Category Rating 10 scale (CR10) is a validated measure of perceived exertion.
Average Distance Walked in 6 Minute Walk Test
Time frame: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
Average distance walked in 6MWT with investigational device (Power Knee) compared to comparator (prescribed device) User walk for 6 minutes in their self selected walking speed on a 30 meter track. Shorter time indicates better mobility performance.
13 secondary outcomes
Total Score of Prosthesis Mobility Questionnaire (PMQ) Questions 9 and 10
Time frame: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
Average Score of Modified Prosthesis Evaluation Questionnaire (PEQ) Question 14F
Time frame: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
Average Score of Modified Prosthesis Evaluation Questionnaire (PEQ) Question 13D
Time frame: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
Satisfaction With Walking Speed
Time frame: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
Prosthetic Limb Users Survey of Mobility (PLUS-M) T-score
Time frame: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
Average Score of Modified Prosthesis Evaluation Questionnaire (PEQ) Question 13A
Time frame: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
Average Score of Prosthesis Evaluation Questionnaire (PEQ) Question 1D
Time frame: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
Average Score Regarding the Ease of Setup
Time frame: Immediately after the intervention (fitting of the investigational device)
Proportion of Participants With Average Score Over 5 on Questions 3K and 3L of the Prosthesis Evaluation Questionnaire (PEQ) With the Investigational Device
Time frame: After 2 weeks of either using the Power Knee or their own prescribed knee
Total Score of Prosthesis Mobility Questionnaire (PMQ) Questions 1 and 3-6:
Time frame: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
Time Required to Complete the L-test
Time frame: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
Average Prosthetic Mobility Questionnaire (PMQ) Total Score
Time frame: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)
Occurrence of Side Effects That Could be Directly Related to Using the Power Knee
Time frame: After 2 weeks of using the Power Knee
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Sep 2025.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Individual participant dataSharing planned: No
Related trials for Prosthesis User
Active, not recruiting
Functional and Neuroprotective Effects of Restoring Lower Limb Sensation After Diabetic Peripheral Neuropathy
Lower Extremity Amputee, Diabetic Peripheral Neuropathy
Recruiting
Impact of Footwear on Gait in Unilateral Transtibial Amputees
Transtibial Amputation, Lower Limb Amputation
Not yet recruiting
Impact of Anterior Load Carriage on Gait in Individuals With Transfemoral Amputation
Unilateral Transfemoral Amputation in Prosthetic Users
Recruiting
Optimize Pattern Recognition Control of Powered Upper Limb Prosthesis
Prosthesis User, Prosthesis
Active, not recruiting
Optimizing Prosthetic Prescription to Mitigate the Effects of Perspiration
Amputation, Prosthesis User
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ian Fothergill, CPO principal investigator
Medical Center Orthotics and Prosthetics (MCOP) Silver Spring
John Warren, CPO principal investigator
Medical Center Orthotics and Prosthetics (MCOP) Boston
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Power Knee in people with Prosthesis User and Amputation, run by Össur Iceland ehf at 2 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 22 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 22 Sep 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Mean Difference in Borg Category Rating Scale Before and After 6MWT at 2 Weeks (time frame: At baseline, after 2 weeks of either using the Power knee or their own prescription prosthesis, and at the fourth follow-up (at approximately weeks 22-16)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2025.